
### [NCIT:C9023](http://purl.obolibrary.org/obo/NCIT_C9023)
**Label:** Sarcoma by FNCLCC Grade

**Subclasses:** [NCIT:C27377](http://purl.obolibrary.org/obo/NCIT_C27377) (Childhood Myxoid Chondrosarcoma), [NCIT:C5525](http://purl.obolibrary.org/obo/NCIT_C5525) (Prostate Embryonal Rhabdomyosarcoma), [NCIT:C5847](http://purl.obolibrary.org/obo/NCIT_C5847) (Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma), [NCIT:C27378](http://purl.obolibrary.org/obo/NCIT_C27378) (Adult Myxoid Chondrosarcoma), [NCIT:C9409](http://purl.obolibrary.org/obo/NCIT_C9409) (Epithelioid Sarcoma NCI Grade 2), [NCIT:C9428](http://purl.obolibrary.org/obo/NCIT_C9428) (Conventional Leiomyosarcoma), [NCIT:C9429](http://purl.obolibrary.org/obo/NCIT_C9429) (Conventional Fibrosarcoma), [NCIT:C3700](http://purl.obolibrary.org/obo/NCIT_C3700) (Epithelioid Leiomyosarcoma), [NCIT:C8799](http://purl.obolibrary.org/obo/NCIT_C8799) (Metastatic Epithelioid Sarcoma), [NCIT:C9426](http://purl.obolibrary.org/obo/NCIT_C9426) (Conventional Angiosarcoma), [NCIT:C7944](http://purl.obolibrary.org/obo/NCIT_C7944) (Adult Epithelioid Sarcoma), [NCIT:C9404](http://purl.obolibrary.org/obo/NCIT_C9404) (Poorly Differentiated Fibrosarcoma), [NCIT:C7943](http://purl.obolibrary.org/obo/NCIT_C7943) (Adult Alveolar Soft Part Sarcoma), [NCIT:C8797](http://purl.obolibrary.org/obo/NCIT_C8797) (Primary Alveolar Soft Part Sarcoma), [NCIT:C9028](http://purl.obolibrary.org/obo/NCIT_C9028) (FNCLCC Sarcoma Grade 2), [NCIT:C8798](http://purl.obolibrary.org/obo/NCIT_C8798) (Recurrent Alveolar Soft Part Sarcoma), [NCIT:C9029](http://purl.obolibrary.org/obo/NCIT_C9029) (FNCLCC Sarcoma Grade 3), [NCIT:C9389](http://purl.obolibrary.org/obo/NCIT_C9389) (Well Differentiated Leiomyosarcoma), [NCIT:C8971](http://purl.obolibrary.org/obo/NCIT_C8971) (Embryonal Rhabdomyosarcoma), [NCIT:C49204](http://purl.obolibrary.org/obo/NCIT_C49204) (Anaplastic Embryonal Rhabdomyosarcoma), [NCIT:C8796](http://purl.obolibrary.org/obo/NCIT_C8796) (Metastatic Alveolar Soft Part Sarcoma), [NCIT:C9024](http://purl.obolibrary.org/obo/NCIT_C9024) (FNCLCC Sarcoma Grade 1), [NCIT:C9025](http://purl.obolibrary.org/obo/NCIT_C9025) (Well Differentiated Fibrosarcoma), [NCIT:C4250](http://purl.obolibrary.org/obo/NCIT_C4250) (Well Differentiated Liposarcoma), [NCIT:C40225](http://purl.obolibrary.org/obo/NCIT_C40225) (Cervical Alveolar Soft Part Sarcoma), [NCIT:C9031](http://purl.obolibrary.org/obo/NCIT_C9031) (Poorly Differentiated Angiosarcoma), [NCIT:C123731](http://purl.obolibrary.org/obo/NCIT_C123731) (Fusion-Positive Alveolar Rhabdomyosarcoma), [NCIT:C123732](http://purl.obolibrary.org/obo/NCIT_C123732) (Fusion-Negative Alveolar Rhabdomyosarcoma), [NCIT:C40320](http://purl.obolibrary.org/obo/NCIT_C40320) (Vulvar Alveolar Soft Part Sarcoma), [NCIT:C8380](http://purl.obolibrary.org/obo/NCIT_C8380) (Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells), [NCIT:C3705](http://purl.obolibrary.org/obo/NCIT_C3705) (Pleomorphic Liposarcoma), [NCIT:C3704](http://purl.obolibrary.org/obo/NCIT_C3704) (Dedifferentiated Liposarcoma), [NCIT:C3749](http://purl.obolibrary.org/obo/NCIT_C3749) (Alveolar Rhabdomyosarcoma), [NCIT:C7809](http://purl.obolibrary.org/obo/NCIT_C7809) (Adult Fibrosarcoma), [NCIT:C27489](http://purl.obolibrary.org/obo/NCIT_C27489) (Spindle Cell Liposarcoma), [NCIT:C5059](http://purl.obolibrary.org/obo/NCIT_C5059) (Recurrent Epithelioid Sarcoma), [NCIT:C3750](http://purl.obolibrary.org/obo/NCIT_C3750) (Alveolar Soft Part Sarcoma), [NCIT:C8800](http://purl.obolibrary.org/obo/NCIT_C8800) (Primary Epithelioid Sarcoma), [NCIT:C4303](http://purl.obolibrary.org/obo/NCIT_C4303) (Myxoid Chondrosarcoma), [NCIT:C4244](http://purl.obolibrary.org/obo/NCIT_C4244) (Infantile Fibrosarcoma), [NCIT:C9410](http://purl.obolibrary.org/obo/NCIT_C9410) (Epithelioid Sarcoma NCI Grade 3), [NCIT:C8095](http://purl.obolibrary.org/obo/NCIT_C8095) (Childhood Epithelioid Sarcoma), [NCIT:C8092](http://purl.obolibrary.org/obo/NCIT_C8092) (Childhood Alveolar Soft Part Sarcoma), [NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma), [NCIT:C3714](http://purl.obolibrary.org/obo/NCIT_C3714) (Epithelioid Sarcoma), [NCIT:C6508](http://purl.obolibrary.org/obo/NCIT_C6508) (Inflammatory Liposarcoma), [NCIT:C128273](http://purl.obolibrary.org/obo/NCIT_C128273) (Vulvar Alveolar Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 57.14%
- Thing 52.12%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 42.50%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 42.50%


